Previous 10 | Next 10 |
GreenLight Biosciences ( NASDAQ: GRNA ) and partner Samsung Biologics announced the successful completion of the first commercial-scale engineering run for the companies' mRNA COVID-19 vaccine. After the announcement of the partnership, technology transfer and sc...
GreenLight’s messenger RNA production process is transferable to large-scale equipment and CMO facilities Technology transfer and scale-up from lab bench to Samsung’s commercial facility was completed in seven months GreenLight’s mRNA synthes...
BOSTON, July 29, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences has announced a collaboration with the National Institutes of Health (NIH) to develop COVID-19 vaccines that are more broadly protective against new variants and with longer-lasting effects. “This is a tremendous ...
Benefit corporations are a new form of business and increasing in number on the market. Similar to ESG metrics, these companies often take it many steps further in regards to positivity. The business structure allows some profits to be syphoned away towards beneficial endeavors, w...
Gainers: NeuroSense Therapeutics NRSN +83%. Axsome Therapeutics (AXSM) +37%. Agile Therapeutics (AGRX) +31%. GreenLight Biosciences (GRNA) +26%. Femasys (FEMY) +11%. Losers: GeoVax Labs GOVX -14%. SIGA Technologies (SIGA) -14%. Eargo (EAR) -12%. BioAtla...
Gainers: Power bridge Technologies (PBTS) +177%. Applied UV (AUVI) +50%. Cardiff Oncology (CRDF) +38%. DBV Technologies (DBVT) +28%. View (VIEW) +24%. Viracta Therapeutics (VIRX) +22%. Finger Motion (FNGR) +21%. Scien joy (SJ) +20%. Aero Clean Technologies (AERC) +19%. Akso Health Group (AHG)...
BOSTON, May 10, 2022 (GLOBE NEWSWIRE) -- An RNA-based solution by GreenLight Biosciences designed to protect honeybees from the Varroa destructor mite was named a finalist by Fast Company for its 2022 World Changing Ideas Awards. This is the first RNA-based solution that d...
GreenLight Biosciences makes affordable and accessible RNA products for human health and agriculture. The company’s cell-free RNA manufacturing platform allows for cost-effective and scalable production of RNA. The company became a publicly listed and Public-Benefit Corpora...
BOSTON, March 29, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences, PBC, a biotechnology company focused on RNA research, product design, development, and manufacturing for human, animal, and plant health, is proud to welcome Barney Graham, MD, PhD., to its Human Health Scientific Advisory B...
Gainers: Incannex Healthcare IXHL +209%. Revelation Biosciences (NASDAQ:REVB) +25%. Co-Diagnostics CODX +14%. GreenLight Biosciences (NASDAQ:GRNA) +14%. Clearside Biomedical (NASDAQ:CLSD) +12%. Losers: Better Therapeutics BTTX -33%. ANI Pharmaceuticals ...
News, Short Squeeze, Breakout and More Instantly...
GreenLight Biosciences Holdings PBC Company Name:
GRNA Stock Symbol:
NASDAQ Market:
GreenLight Biosciences Holdings PBC (GRNA) is expected to report for Q2 2023
LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced the closing of its previously announced merger with SW MergerCo, Inc. (“Merger Sub”) and SW ParentCo, I...
NEW YORK, NY / ACCESSWIRE / June 26, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Conformis, Inc. (NASDAQ:CFMS)'s sale t...